BIO Europe in Stockholm was characterized by openness and collaboration. The meeting is of great importance for biotech innovation and addresses the latest trends, challenges and opportunities in life sciences, inspiring further developments and future partnerships. The company’s CEO, Peter Ekolind, and the Chief Scientific Officer, Annika Ericsson, participated in BIO Europe.
A total of 2,800 companies and 5,500 delegates from more than 60 countries participated in the meeting. During this event, Peter Ekolind CombiGene’s CEO, presented the epilepsy and COZY programs for approximately 50 delegates. This led to several interesting discussions and meetings with companies relevant to CombiGene. Several meetings with pharmaceutical companies were scheduled even before the actual meeting started. Follow-up meetings are planned and have already begun to take place